283 related articles for article (PubMed ID: 21345949)
1. TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements.
Kajaste-Rudnitski A; Marelli SS; Pultrone C; Pertel T; Uchil PD; Mechti N; Mothes W; Poli G; Luban J; Vicenzi E
J Virol; 2011 May; 85(10):5183-96. PubMed ID: 21345949
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter.
Turrini F; Marelli S; Kajaste-Rudnitski A; Lusic M; Van Lint C; Das AT; Harwig A; Berkhout B; Vicenzi E
Retrovirology; 2015 Dec; 12():104. PubMed ID: 26683615
[TBL] [Abstract][Full Text] [Related]
3. The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells.
Forlani G; Turrini F; Ghezzi S; Tedeschi A; Poli G; Accolla RS; Tosi G
J Transl Med; 2016 Apr; 14():94. PubMed ID: 27089879
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cells.
Su Y; Popik W; Pitha PM
J Virol; 1995 Jan; 69(1):110-21. PubMed ID: 7983701
[TBL] [Abstract][Full Text] [Related]
5. Identification of TRIM22 single nucleotide polymorphisms associated with loss of inhibition of HIV-1 transcription and advanced HIV-1 disease.
Ghezzi S; Galli L; Kajaste-Rudnitski A; Turrini F; Marelli S; Toniolo D; Casoli C; Riva A; Poli G; Castagna A; Vicenzi E
AIDS; 2013 Sep; 27(15):2335-44. PubMed ID: 23921607
[TBL] [Abstract][Full Text] [Related]
6. Semen Exosomes Promote Transcriptional Silencing of HIV-1 by Disrupting NF-κB/Sp1/Tat Circuitry.
Welch JL; Kaddour H; Schlievert PM; Stapleton JT; Okeoma CM
J Virol; 2018 Nov; 92(21):. PubMed ID: 30111566
[TBL] [Abstract][Full Text] [Related]
7. TRIM5α and TRIM22 are differentially regulated according to HIV-1 infection phase and compartment.
Singh R; Patel V; Mureithi MW; Naranbhai V; Ramsuran D; Tulsi S; Hiramen K; Werner L; Mlisana K; Altfeld M; Luban J; Kasprowicz V; Dheda K; Abdool Karim SS; Ndung'u T
J Virol; 2014 Apr; 88(8):4291-303. PubMed ID: 24478420
[TBL] [Abstract][Full Text] [Related]
8. Tripartite Motif-Containing Protein 22 Interacts with Class II Transactivator and Orchestrates Its Recruitment in Nuclear Bodies Containing TRIM19/PML and Cyclin T1.
Forlani G; Tosi G; Turrini F; Poli G; Vicenzi E; Accolla RS
Front Immunol; 2017; 8():564. PubMed ID: 28555140
[TBL] [Abstract][Full Text] [Related]
9. The interferon-stimulated gene TRIM22: A double-edged sword in HIV-1 infection.
Vicenzi E; Poli G
Cytokine Growth Factor Rev; 2018 Apr; 40():40-47. PubMed ID: 29650252
[TBL] [Abstract][Full Text] [Related]
10. TRIM22. A Multitasking Antiviral Factor.
Pagani I; Poli G; Vicenzi E
Cells; 2021 Jul; 10(8):. PubMed ID: 34440633
[TBL] [Abstract][Full Text] [Related]
11. TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα.
Ji J; Ding K; Luo T; Zhang X; Chen A; Zhang D; Li G; Thorsen F; Huang B; Li X; Wang J
Cell Death Differ; 2021 Jan; 28(1):367-381. PubMed ID: 32814880
[TBL] [Abstract][Full Text] [Related]
12. The interferon response inhibits HIV particle production by induction of TRIM22.
Barr SD; Smiley JR; Bushman FD
PLoS Pathog; 2008 Feb; 4(2):e1000007. PubMed ID: 18389079
[TBL] [Abstract][Full Text] [Related]
13. H. saimiri tyrosine-kinase interacting protein inhibits Tat function: a prototypic strategy for restricting HIV-1-induced cytopathic effects in immune cells.
Raymond AD; Hasham M; Tsygankov AY; Henderson EE
Virology; 2006 Sep; 352(2):253-67. PubMed ID: 16780912
[TBL] [Abstract][Full Text] [Related]
14. Identification of tripartite motif-containing 22 (TRIM22) as a novel NF-κB activator.
Yu S; Gao B; Duan Z; Xu W; Xiong S
Biochem Biophys Res Commun; 2011 Jul; 410(2):247-51. PubMed ID: 21651891
[TBL] [Abstract][Full Text] [Related]
15. Activation of HIV-1 long terminal repeat transcription and virus replication via NF-kappaB-dependent and -independent pathways by potent phosphotyrosine phosphatase inhibitors, the peroxovanadium compounds.
Barbeau B; Bernier R; Dumais N; Briand G; Olivier M; Faure R; Posner BI; Tremblay M
J Biol Chem; 1997 May; 272(20):12968-77. PubMed ID: 9148903
[TBL] [Abstract][Full Text] [Related]
16. miR-215 Enhances HCV Replication by Targeting TRIM22 and Inactivating NF-κB Signaling.
Tian H; He Z
Yonsei Med J; 2018 Jun; 59(4):511-518. PubMed ID: 29749134
[TBL] [Abstract][Full Text] [Related]
17. Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection.
Singh R; Gaiha G; Werner L; McKim K; Mlisana K; Luban J; Walker BD; Karim SS; Brass AL; Ndung'u T;
J Virol; 2011 Jan; 85(1):208-16. PubMed ID: 20980524
[TBL] [Abstract][Full Text] [Related]
18. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
[TBL] [Abstract][Full Text] [Related]
19. TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation.
Di Pietro A; Kajaste-Rudnitski A; Oteiza A; Nicora L; Towers GJ; Mechti N; Vicenzi E
J Virol; 2013 Apr; 87(8):4523-33. PubMed ID: 23408607
[TBL] [Abstract][Full Text] [Related]
20. NF-κB-Interacting Long Noncoding RNA Regulates HIV-1 Replication and Latency by Repressing NF-κB Signaling.
Wang H; Liu Y; Huan C; Yang J; Li Z; Zheng B; Wang Y; Zhang W
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]